These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 30196375

  • 21. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B, Cortet C, Blanckaert F, d'Herbomez M, Marchandise X, Wémeau J-L, Decoulx M, Dewailly D.
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [Abstract] [Full Text] [Related]

  • 22. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 23. The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland.
    Everts-Graber J, Wenger M, Oser S, Studer U, Steiner C, Ziswiler HR, Sromek K, Schmid G, Gahl B, Häuselmann H, Reichenbach S, Lehmann T.
    Osteoporos Int; 2024 Sep; 35(9):1605-1613. PubMed ID: 38922397
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
    Jiajue R, Jiang Y, Qi X, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W.
    Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
    [Abstract] [Full Text] [Related]

  • 27. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T.
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [Abstract] [Full Text] [Related]

  • 28. Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.
    Seguro LP, Casella CB, Caparbo VF, Oliveira RM, Bonfa A, Bonfa E, Pereira RM.
    Osteoporos Int; 2015 Feb; 26(2):459-67. PubMed ID: 25146092
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association between changes in serum bone metabolism markers and bone microarchitecture changes during basic combat training - The ARMI study.
    Coulombe JC, Bozzini BN, Guerriere KI, Foulis SA, Reynoso M, Walker LA, Staab JS, Bouxsein ML, Hughes JM, Popp KL.
    Bone; 2024 Dec; 189():117241. PubMed ID: 39182596
    [Abstract] [Full Text] [Related]

  • 31. [Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].
    Ageev FT, Barinova IV, Seredenina EM, Orlova IaA, Kuz'mina AE, Masenko VP, Kochetov AG.
    Kardiologiia; 2013 Dec; 53(6):51-8. PubMed ID: 23953046
    [Abstract] [Full Text] [Related]

  • 32. Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.
    Zhu L, Zhang J, Wang J, Lv X, Pu D, Wang Y, Men Q, He L.
    Lupus; 2021 Jun; 30(7):1116-1123. PubMed ID: 33832361
    [Abstract] [Full Text] [Related]

  • 33. Correlation of plasma microRNA-21 expression and bone turnover markers in postmenopausal women.
    Perksanusak T, Panyakhamlerd K, Hirankarn N, Suwan A, Vasuratna A, Taechakraichana N.
    Climacteric; 2018 Dec; 21(6):581-585. PubMed ID: 30232913
    [Abstract] [Full Text] [Related]

  • 34. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR.
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bone remodeling and bone mineral density during pregnancy.
    Ulrich U, Miller PB, Eyre DR, Chesnut CH, Schlebusch H, Soules MR.
    Arch Gynecol Obstet; 2003 Oct; 268(4):309-16. PubMed ID: 14504876
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
    Wisłowska M, Jakubicz D, Stepień K, Cicha M.
    Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density.
    Scariano JK, Garry PJ, Montoya GD, Duran-Valdez E, Baumgartner RN.
    Scand J Clin Lab Invest; 2002 Oct; 62(3):237-43. PubMed ID: 12088343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.